Ivermectin-d2

• Description :

  Ivermectin-d2 is deuterium labeled Ivermectin[1].

• UNSPSC :

  12352005

• Target :

  Isotope-Labeled Compounds

• Type :

  Reference compound

• Related Pathways :

  Others

• Field of Research :

  Others

• Purity :

  97.63

• Smiles :

  C/C([C@H]([C@@H](C)/C=C/C=C1CO[C@@]2([H])[C@@]\1([C@@](C=C(C)[C@H]2O)3[H])O)O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)=C\C[C@]6([H])C[C@@H](C[C@@]7(O[C@]([C@@H](C)C([2H])[C@H]7[2H])([H])[C@@](C)(CC)[H])O6)OC3=O

• Molecular Formula :

  C48H72D2O14

• Molecular Weight :

  877.11

• References & Citations :

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported